205 related articles for article (PubMed ID: 21713025)
1. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy.
Parry CM; Vinh H; Chinh NT; Wain J; Campbell JI; Hien TT; Farrar JJ; Baker S
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1163. PubMed ID: 21713025
[TBL] [Abstract][Full Text] [Related]
2. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
Parry CM; Thuy CT; Dongol S; Karkey A; Vinh H; Chinh NT; Duy PT; Thieu Nga TV; Campbell JI; Van Minh Hoang N; Arjyal A; Bhutta ZA; Bhattacharya SK; Agtini MD; Dong B; Canh DG; Naheed A; Wain J; Tinh Hien T; Basnyat B; Ochiai L; Clemens J; Farrar JJ; Dolecek C; Baker S
Antimicrob Agents Chemother; 2010 Dec; 54(12):5201-8. PubMed ID: 20837759
[TBL] [Abstract][Full Text] [Related]
3. Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever.
Koirala KD; Thanh DP; Thapa SD; Arjyal A; Karkey A; Dongol S; Shrestha UM; Farrar JJ; Basnyat B; Baker S
Antimicrob Agents Chemother; 2012 May; 56(5):2761-2. PubMed ID: 22371897
[TBL] [Abstract][Full Text] [Related]
4. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
5. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.
Crump JA; Kretsinger K; Gay K; Hoekstra RM; Vugia DJ; Hurd S; Segler SD; Megginson M; Luedeman LJ; Shiferaw B; Hanna SS; Joyce KW; Mintz ED; Angulo FJ;
Antimicrob Agents Chemother; 2008 Apr; 52(4):1278-84. PubMed ID: 18212096
[TBL] [Abstract][Full Text] [Related]
6. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance.
Mandal S; Mandal MD; Pal NK
Jpn J Infect Dis; 2003; 56(5-6):210-2. PubMed ID: 14695432
[TBL] [Abstract][Full Text] [Related]
7. Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.
Thompson CN; Karkey A; Dongol S; Arjyal A; Wolbers M; Darton T; Farrar JJ; Thwaites GE; Dolecek C; Basnyat B; Baker S
Clin Infect Dis; 2017 Jun; 64(11):1522-1531. PubMed ID: 28329181
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
Joshi S; Amarnath SK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):308-10. PubMed ID: 16950486
[TBL] [Abstract][Full Text] [Related]
9. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
Zafar A; Ibrahim NG; Ahsan T; Abbas Z; Zaidi A; Hasan R
J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870
[TBL] [Abstract][Full Text] [Related]
10. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.
Manchanda V; Bhalla P; Sethi M; Sharma VK
Indian J Med Microbiol; 2006 Apr; 24(2):101-6. PubMed ID: 16687859
[TBL] [Abstract][Full Text] [Related]
11. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
12. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
Ray P; Sharma J; Marak RS; Garg RK
Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.
Parry CM; Ho VA; Phuong le T; Bay PV; Lanh MN; Tung le T; Tham NT; Wain J; Hien TT; Farrar JJ
Antimicrob Agents Chemother; 2007 Mar; 51(3):819-25. PubMed ID: 17145784
[TBL] [Abstract][Full Text] [Related]
14. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
15. Lower Susceptibility to Fluoroquinolones and a gyrA Gene Mutation in Salmonella Typhi Isolates from Enteric Fever Patients.
Shrestha SK; Khadka S; Rayamajhee B; Thapa A; Sharma S; Shrestha B; Poudel P
J Nepal Health Res Counc; 2022 Nov; 20(2):517-523. PubMed ID: 36550738
[TBL] [Abstract][Full Text] [Related]
16. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
[No Abstract] [Full Text] [Related]
17. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
18. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
[TBL] [Abstract][Full Text] [Related]
19. A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India.
Harish BN; Menezes GA; Sarangapani K; Parija SC
J Infect Dev Ctries; 2008 Aug; 2(4):324-7. PubMed ID: 19741296
[TBL] [Abstract][Full Text] [Related]
20. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Gaborieau V; Weill FX; Marchou B
Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
